Country: Írland
Tungumál: enska
Heimild: HPRA (Health Products Regulatory Authority)
Adrenaline
DLRC Pharma Services Limited
C01CA; C01CA24
Adrenaline
0.1 milligram(s)/millilitre
Solution for injection
Adrenergic and dopaminergic agents; epinephrine
Not marketed
1978-01-25
ADRENALINE (EPINEPHRINE) 1:10,000 STERILE SOLUTION MINIJET SOLUTION FOR INJECTION Please note this medicine is mainly used in emergency situations and the doctor will have decided that you needed it. It is unlikely, therefore, that you the medicine was administered to you. − to read it again − If you have any further questions, ask the doctor or nurse − This medicine has been prescribed for you. Do not pass it onto others. It may harm them, even if their symptoms are the same as yours. − If any of the side effects get serious, or if you notice any side please tell the doctor or nurse. − 1:10,000 Sterile Solution Minijet will be called Adrenaline Minijet 1. What Adrenaline Minijet is and what it is used for 2. Before you are given Adrenaline Minijet 3. How Adrenaline Minijet is used 4. Possible side effects 5. How to store Adrenaline Minijet 6. Further information. 1. WHAT ADRENALINE STERILE SOLUTION MINIJET IS AND WHAT IT IS USED FOR Adrenaline is a type of drug that constricts blood vessels, makes the heart pump more strongly and opens airways. It is used in life-threatening emergencies such as when the heart has stopped beating. It will have been used to save your life. 2. BEFORE YOU ARE GIVEN ADRENALINE MINIJET In emergencies, it may be impossible for the people looking after you to get all your details before they have to treat you. They will have assessed the situation and decided it was better to give you the injection now and ask questions later. PLEASE TELL YOUR DOCTOR IF: • you are allergic to any of the ingredients (listed in section rarely cause hypersensitivity reactions and bronchospasm 6). Sodium metabisulfite may • you suffer from hyperthyroidism (overactive thyroid gland) • you suffer from hypertension (high blood pressure) • you suffer from heart disease or long standing chest disease like asthma or emphysema • you suffer from diabetes • you suffer from closed angle glaucoma (an eye condition that causes sudden blurred vision with pain and redness) • you are allergic to sy Lestu allt skjalið
Health Products Regulatory Authority 29 May 2019 CRN008TLL Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Adrenaline (Epinephrine) 1:10,000 Sterile Solution Minijet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Adrenaline (Epinephrine) 0.1 mg per ml, in total volume presentations of 0.3 mg / 3 ml and 1 mg / 10 ml. Excipients with known effect: sodium metabisulfite (E223) 1 mg in 1 ml and total sodium 2.7mg in 1 ml. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. Clear, colourless solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Adjunctive use in the management of cardiac arrest. In cardiopulmonary resuscitation. Intracardiac puncture and intramyocardial injection of adrenaline may be effective when external cardiac compression and attempts to restore the circulation by electrical defibrillation or use of a pacemaker fail. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION VENTRICULAR FIBRILLATION (PULSELESS VENTRICULAR TACHYCARDIA) Adults: _Intravenous injection_ 10ml (1mg) by intravenous injection repeated every 3-5 minutes as necessary. _Endotracheal_ 20-30ml (2-3mg) via an endotracheal tube, repeated as necessary. _Intracardiac injection_ 1 to 10ml (0.1 to 1mg), direct into the atrium of the heart. Intracardiac injection should only be considered if there is no other access available. It should be undertaken by personnel trained in the technique. Children: _Intravenous injection_ Initially 0.1ml/kg body weight (10mcg/kg); e.g. 2kg infant would receive 0.2ml of Adrenaline 1:10,000. Subsequent doses should be 1ml/kg (100mcg/kg). _Intraosseous_ 0.1ml/kg body weight (10mcg/kg). _Endotracheal_ A dose has not been established; 10 times the intravenous dose may be appropriate. Asystole Health Products Regulatory Authority 29 May 2019 CRN008TLL Page 2 of 5 Adults: _Intravenous_ 10ml (1mg) by intravenous injection repeated every 3-5 minutes as necessary. If there is no response after three cycles, consider injections of adrenaline 5mg. _End Lestu allt skjalið